Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vagina | 20 | 2024 | 837 | 4.040 |
Why?
|
Lactobacillus | 12 | 2024 | 204 | 3.110 |
Why?
|
Vaginosis, Bacterial | 9 | 2024 | 142 | 2.990 |
Why?
|
HIV Infections | 54 | 2024 | 17165 | 2.230 |
Why?
|
HIV-1 | 25 | 2024 | 6849 | 1.290 |
Why?
|
CD4-Positive T-Lymphocytes | 18 | 2021 | 4353 | 1.200 |
Why?
|
Metagenomics | 3 | 2019 | 457 | 1.030 |
Why?
|
Cervix Uteri | 4 | 2020 | 582 | 1.020 |
Why?
|
Premature Birth | 4 | 2023 | 1771 | 0.830 |
Why?
|
Host-Pathogen Interactions | 4 | 2021 | 1447 | 0.780 |
Why?
|
Enterococcus faecium | 1 | 2021 | 101 | 0.730 |
Why?
|
Viral Tropism | 1 | 2021 | 102 | 0.710 |
Why?
|
Interleukin-10 | 4 | 2013 | 1175 | 0.640 |
Why?
|
RNA, Ribosomal, 16S | 6 | 2023 | 1006 | 0.640 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2021 | 343 | 0.640 |
Why?
|
Mycobacterium tuberculosis | 4 | 2023 | 1903 | 0.620 |
Why?
|
Macrophages, Alveolar | 1 | 2021 | 409 | 0.620 |
Why?
|
Respiratory Mucosa | 1 | 2021 | 441 | 0.610 |
Why?
|
Up-Regulation | 4 | 2017 | 4122 | 0.600 |
Why?
|
Viral Load | 11 | 2021 | 3322 | 0.600 |
Why?
|
Tobacco Smoke Pollution | 1 | 2023 | 812 | 0.590 |
Why?
|
Immunity, Mucosal | 2 | 2018 | 482 | 0.580 |
Why?
|
beta-Defensins | 1 | 2017 | 59 | 0.570 |
Why?
|
CD8-Positive T-Lymphocytes | 11 | 2021 | 4550 | 0.560 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2018 | 345 | 0.550 |
Why?
|
Fatty Acids | 1 | 2024 | 1804 | 0.540 |
Why?
|
Monocytes | 5 | 2023 | 2575 | 0.510 |
Why?
|
Obstetric Labor Complications | 1 | 2018 | 236 | 0.510 |
Why?
|
Tuberculosis | 3 | 2023 | 2001 | 0.480 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2019 | 538 | 0.480 |
Why?
|
Contraceptive Agents, Female | 1 | 2015 | 118 | 0.470 |
Why?
|
HIV | 8 | 2019 | 1579 | 0.460 |
Why?
|
South Africa | 7 | 2022 | 1821 | 0.460 |
Why?
|
Intestinal Mucosa | 5 | 2024 | 3022 | 0.450 |
Why?
|
Progestins | 1 | 2015 | 302 | 0.450 |
Why?
|
T-Lymphocyte Subsets | 3 | 2018 | 1810 | 0.430 |
Why?
|
Interferon Type I | 1 | 2017 | 559 | 0.420 |
Why?
|
Anti-HIV Agents | 6 | 2021 | 4491 | 0.400 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2019 | 831 | 0.400 |
Why?
|
Sequence Analysis, RNA | 2 | 2019 | 2005 | 0.390 |
Why?
|
Prevotella | 2 | 2024 | 80 | 0.380 |
Why?
|
Bronchoalveolar Lavage Fluid | 3 | 2021 | 748 | 0.370 |
Why?
|
Inflammation | 7 | 2023 | 10756 | 0.340 |
Why?
|
Bacteria | 6 | 2024 | 2199 | 0.330 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2021 | 3075 | 0.310 |
Why?
|
Cytokines | 14 | 2023 | 7343 | 0.310 |
Why?
|
Smoking | 2 | 2021 | 9073 | 0.290 |
Why?
|
Humans | 88 | 2024 | 760621 | 0.290 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3224 | 0.270 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2019 | 3616 | 0.270 |
Why?
|
Female | 51 | 2024 | 391270 | 0.260 |
Why?
|
Anti-Retroviral Agents | 4 | 2022 | 1779 | 0.260 |
Why?
|
Mucous Membrane | 4 | 2022 | 657 | 0.250 |
Why?
|
Immunophenotyping | 5 | 2018 | 1871 | 0.250 |
Why?
|
Receptors, CCR5 | 4 | 2021 | 488 | 0.240 |
Why?
|
Germinal Center | 2 | 2024 | 379 | 0.240 |
Why?
|
Antigen-Presenting Cells | 2 | 2021 | 967 | 0.240 |
Why?
|
Oleic Acid | 1 | 2024 | 92 | 0.230 |
Why?
|
RNA, Viral | 4 | 2022 | 2838 | 0.230 |
Why?
|
Neuraminidase | 1 | 2024 | 200 | 0.230 |
Why?
|
Phylogeny | 3 | 2021 | 2775 | 0.230 |
Why?
|
Lectins, C-Type | 2 | 2011 | 587 | 0.230 |
Why?
|
Mycoses | 1 | 2007 | 387 | 0.230 |
Why?
|
B-Lymphocytes | 3 | 2024 | 4742 | 0.220 |
Why?
|
HLA-B Antigens | 3 | 2017 | 331 | 0.220 |
Why?
|
Feces | 2 | 2022 | 1455 | 0.210 |
Why?
|
Plasma Cells | 2 | 2024 | 591 | 0.210 |
Why?
|
Receptors, Cell Surface | 3 | 2018 | 2825 | 0.200 |
Why?
|
Antifungal Agents | 1 | 2007 | 749 | 0.200 |
Why?
|
Carotid Artery Diseases | 2 | 2021 | 883 | 0.200 |
Why?
|
Lung | 4 | 2023 | 9994 | 0.200 |
Why?
|
Triazoles | 1 | 2007 | 904 | 0.190 |
Why?
|
Virus Replication | 6 | 2018 | 2432 | 0.190 |
Why?
|
Flow Cytometry | 7 | 2017 | 5870 | 0.190 |
Why?
|
Leukocytes, Mononuclear | 3 | 2020 | 1827 | 0.190 |
Why?
|
Anti-Bacterial Agents | 5 | 2024 | 7408 | 0.190 |
Why?
|
Immunoglobulin A | 1 | 2024 | 979 | 0.190 |
Why?
|
Chemokine CCL5 | 1 | 2021 | 215 | 0.190 |
Why?
|
Lectins | 2 | 2002 | 484 | 0.180 |
Why?
|
Metronidazole | 1 | 2022 | 231 | 0.180 |
Why?
|
Receptors, CXCR3 | 1 | 2021 | 238 | 0.180 |
Why?
|
Immunization | 2 | 2023 | 1227 | 0.180 |
Why?
|
Chemokine CXCL10 | 1 | 2021 | 316 | 0.180 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2018 | 282 | 0.180 |
Why?
|
Immunocompromised Host | 2 | 2020 | 857 | 0.170 |
Why?
|
Herpesvirus 8, Human | 1 | 2021 | 255 | 0.170 |
Why?
|
T-Lymphocytes | 5 | 2021 | 10181 | 0.170 |
Why?
|
Microbial Sensitivity Tests | 2 | 2021 | 1949 | 0.170 |
Why?
|
Acinetobacter Infections | 1 | 2020 | 71 | 0.170 |
Why?
|
Metagenome | 2 | 2023 | 450 | 0.170 |
Why?
|
AIDS Vaccines | 2 | 2016 | 895 | 0.170 |
Why?
|
Parturition | 1 | 2023 | 446 | 0.170 |
Why?
|
Immunoglobulin Variable Region | 1 | 2020 | 419 | 0.160 |
Why?
|
Pregnancy | 8 | 2023 | 29749 | 0.160 |
Why?
|
HLA-C Antigens | 2 | 2017 | 147 | 0.160 |
Why?
|
Viremia | 4 | 2024 | 707 | 0.160 |
Why?
|
Endopeptidases | 1 | 2023 | 772 | 0.160 |
Why?
|
Antigens, CD | 5 | 2018 | 4000 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 165 | 0.160 |
Why?
|
Acinetobacter baumannii | 1 | 2020 | 115 | 0.160 |
Why?
|
Receptors, IgG | 1 | 2022 | 559 | 0.160 |
Why?
|
Lymphoid Tissue | 4 | 2014 | 445 | 0.160 |
Why?
|
Uganda | 6 | 2021 | 1324 | 0.160 |
Why?
|
Urban Health | 1 | 2021 | 533 | 0.160 |
Why?
|
Sarcoma, Kaposi | 1 | 2021 | 376 | 0.160 |
Why?
|
Chemotaxis | 1 | 2021 | 598 | 0.160 |
Why?
|
Lymphocyte Count | 2 | 2018 | 780 | 0.160 |
Why?
|
Interleukins | 2 | 2015 | 785 | 0.150 |
Why?
|
Computational Biology | 2 | 2021 | 3505 | 0.150 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2021 | 662 | 0.150 |
Why?
|
Cell Adhesion Molecules | 3 | 2011 | 1602 | 0.150 |
Why?
|
Macrophages | 3 | 2023 | 5745 | 0.150 |
Why?
|
Gastrointestinal Tract | 2 | 2022 | 830 | 0.150 |
Why?
|
Pulmonary Circulation | 1 | 2020 | 743 | 0.150 |
Why?
|
Pulmonary Alveoli | 1 | 2020 | 653 | 0.140 |
Why?
|
Interferon-gamma | 6 | 2020 | 3157 | 0.140 |
Why?
|
Cysteine | 1 | 2022 | 895 | 0.140 |
Why?
|
Inflammation Mediators | 4 | 2018 | 1881 | 0.140 |
Why?
|
Bacteria, Anaerobic | 1 | 2017 | 70 | 0.140 |
Why?
|
Young Adult | 12 | 2021 | 58741 | 0.140 |
Why?
|
Simian immunodeficiency virus | 2 | 2019 | 805 | 0.140 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2018 | 296 | 0.140 |
Why?
|
HIV Seropositivity | 1 | 2021 | 955 | 0.130 |
Why?
|
Homosexuality, Male | 1 | 2024 | 1273 | 0.130 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2016 | 148 | 0.130 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 886 | 0.130 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2011 | 1135 | 0.130 |
Why?
|
Enterobacteriaceae | 1 | 2017 | 172 | 0.130 |
Why?
|
Transposases | 1 | 1995 | 103 | 0.120 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 249 | 0.120 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2016 | 206 | 0.120 |
Why?
|
Genome, Viral | 1 | 2019 | 658 | 0.120 |
Why?
|
Africa South of the Sahara | 1 | 2018 | 742 | 0.120 |
Why?
|
DNA Transposable Elements | 2 | 1996 | 756 | 0.120 |
Why?
|
Sexually Transmitted Diseases | 1 | 2020 | 628 | 0.120 |
Why?
|
Sequence Analysis | 1 | 2015 | 240 | 0.120 |
Why?
|
Bacterial Proteins | 3 | 2024 | 3826 | 0.120 |
Why?
|
Infant, Newborn | 4 | 2023 | 26181 | 0.120 |
Why?
|
HEK293 Cells | 3 | 2019 | 4264 | 0.120 |
Why?
|
Electron Microscope Tomography | 1 | 2014 | 17 | 0.120 |
Why?
|
Immunologic Memory | 2 | 2018 | 1354 | 0.120 |
Why?
|
Sexual Behavior | 1 | 2024 | 2086 | 0.120 |
Why?
|
Drug Resistance, Bacterial | 1 | 2021 | 1055 | 0.120 |
Why?
|
Probiotics | 1 | 2018 | 377 | 0.110 |
Why?
|
Male | 27 | 2024 | 359744 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 582 | 0.110 |
Why?
|
Nucleotidyltransferases | 1 | 1995 | 244 | 0.110 |
Why?
|
Disease Transmission, Infectious | 1 | 2019 | 558 | 0.110 |
Why?
|
Rural Population | 3 | 2018 | 2268 | 0.110 |
Why?
|
HIV Antibodies | 2 | 2017 | 1300 | 0.110 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 621 | 0.110 |
Why?
|
Adult | 18 | 2024 | 219994 | 0.110 |
Why?
|
Hyperalgesia | 1 | 2017 | 530 | 0.110 |
Why?
|
Africa | 1 | 2015 | 705 | 0.110 |
Why?
|
Case-Control Studies | 6 | 2021 | 22053 | 0.110 |
Why?
|
Brain Diseases | 1 | 2022 | 1540 | 0.100 |
Why?
|
Injections | 1 | 2015 | 830 | 0.100 |
Why?
|
Lipopolysaccharides | 1 | 2020 | 2209 | 0.100 |
Why?
|
Postmenopause | 1 | 2021 | 2509 | 0.100 |
Why?
|
Macaca mulatta | 1 | 2019 | 2316 | 0.100 |
Why?
|
Biodiversity | 1 | 2015 | 345 | 0.100 |
Why?
|
Contraception | 1 | 2015 | 349 | 0.100 |
Why?
|
Receptors, Fc | 1 | 2016 | 534 | 0.100 |
Why?
|
Gene Expression Profiling | 3 | 2020 | 9411 | 0.100 |
Why?
|
Cohort Studies | 9 | 2020 | 41335 | 0.100 |
Why?
|
Viruses | 1 | 2016 | 376 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1791 | 0.100 |
Why?
|
Lymph Nodes | 2 | 2023 | 3486 | 0.100 |
Why?
|
Chemokines, CXC | 1 | 2013 | 421 | 0.100 |
Why?
|
Lymphocyte Activation | 6 | 2021 | 5496 | 0.100 |
Why?
|
Virion | 1 | 2014 | 421 | 0.100 |
Why?
|
Interleukin-6 | 2 | 2018 | 3215 | 0.100 |
Why?
|
Killer Cells, Natural | 2 | 2017 | 2203 | 0.090 |
Why?
|
Middle Aged | 19 | 2022 | 220352 | 0.090 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 305 | 0.090 |
Why?
|
Cross Infection | 1 | 2020 | 1434 | 0.090 |
Why?
|
Vaccination | 1 | 2023 | 3361 | 0.090 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2010 | 151 | 0.090 |
Why?
|
Phagocytosis | 1 | 2016 | 1535 | 0.090 |
Why?
|
Genes, MHC Class I | 1 | 2010 | 240 | 0.090 |
Why?
|
Antibodies, Neutralizing | 2 | 2017 | 1933 | 0.090 |
Why?
|
C-Reactive Protein | 2 | 2018 | 3839 | 0.080 |
Why?
|
Antibody Formation | 1 | 2014 | 1400 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2192 | 0.080 |
Why?
|
Prospective Studies | 6 | 2021 | 54303 | 0.080 |
Why?
|
Dendritic Cells | 2 | 2016 | 2725 | 0.080 |
Why?
|
Receptors, HIV | 2 | 2000 | 159 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4713 | 0.080 |
Why?
|
Mice | 8 | 2023 | 81208 | 0.080 |
Why?
|
Bronchoalveolar Lavage | 2 | 2020 | 129 | 0.080 |
Why?
|
Research Design | 2 | 2021 | 6180 | 0.080 |
Why?
|
Positron-Emission Tomography | 2 | 2022 | 6465 | 0.070 |
Why?
|
Risk | 2 | 2019 | 9631 | 0.070 |
Why?
|
Gene Knockout Techniques | 1 | 2010 | 802 | 0.070 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2016 | 1894 | 0.070 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2016 | 2197 | 0.070 |
Why?
|
Drug Resistance, Fungal | 1 | 2007 | 73 | 0.070 |
Why?
|
Animals | 11 | 2023 | 167963 | 0.070 |
Why?
|
Poverty | 1 | 2018 | 2695 | 0.070 |
Why?
|
Cadherins | 1 | 2011 | 898 | 0.070 |
Why?
|
Adenoma | 1 | 2017 | 2148 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2017 | 2093 | 0.070 |
Why?
|
Homeostasis | 1 | 2017 | 3306 | 0.060 |
Why?
|
Colorectal Neoplasms | 2 | 2017 | 6853 | 0.060 |
Why?
|
Carcinoma | 1 | 2017 | 2331 | 0.060 |
Why?
|
Antigen Presentation | 1 | 2010 | 1254 | 0.060 |
Why?
|
Gene Expression | 4 | 2023 | 7588 | 0.060 |
Why?
|
Antiviral Agents | 1 | 2017 | 3061 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2014 | 2536 | 0.060 |
Why?
|
Intestines | 1 | 2014 | 1907 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3364 | 0.060 |
Why?
|
Fungi | 1 | 2007 | 339 | 0.060 |
Why?
|
HLA-A Antigens | 2 | 2017 | 225 | 0.060 |
Why?
|
Lab-On-A-Chip Devices | 2 | 2022 | 432 | 0.060 |
Why?
|
Polymorphism, Genetic | 2 | 2013 | 4291 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25942 | 0.060 |
Why?
|
Risk Factors | 5 | 2021 | 74359 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2016 | 12766 | 0.050 |
Why?
|
Peptide Fragments | 1 | 1995 | 5125 | 0.050 |
Why?
|
Single-Cell Analysis | 1 | 2014 | 2380 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3426 | 0.050 |
Why?
|
Adolescent | 5 | 2020 | 87810 | 0.050 |
Why?
|
Pain | 1 | 2017 | 5066 | 0.050 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2022 | 133 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2015 | 11903 | 0.050 |
Why?
|
Glycerol | 1 | 2022 | 276 | 0.050 |
Why?
|
Phosphate-Binding Proteins | 1 | 2022 | 93 | 0.050 |
Why?
|
Caspase 1 | 1 | 2022 | 226 | 0.050 |
Why?
|
Trans-Activators | 1 | 2011 | 2860 | 0.050 |
Why?
|
Minnesota | 1 | 2021 | 340 | 0.050 |
Why?
|
Mucins | 1 | 2024 | 568 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12531 | 0.050 |
Why?
|
Disease Progression | 5 | 2021 | 13502 | 0.050 |
Why?
|
CD4 Lymphocyte Count | 2 | 2018 | 2569 | 0.050 |
Why?
|
Cells, Cultured | 5 | 2019 | 18957 | 0.050 |
Why?
|
Salvage Therapy | 1 | 2007 | 1268 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2014 | 10446 | 0.040 |
Why?
|
Kenya | 1 | 2023 | 749 | 0.040 |
Why?
|
Herpesviridae Infections | 1 | 2021 | 270 | 0.040 |
Why?
|
Physicians | 1 | 2018 | 4591 | 0.040 |
Why?
|
Menstrual Cycle | 1 | 2023 | 536 | 0.040 |
Why?
|
Disease Outbreaks | 2 | 2020 | 1758 | 0.040 |
Why?
|
Blood Buffy Coat | 1 | 2019 | 11 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2016 | 3517 | 0.040 |
Why?
|
Signal Transduction | 3 | 2019 | 23376 | 0.040 |
Why?
|
Live Birth | 1 | 2023 | 512 | 0.040 |
Why?
|
Burn Units | 1 | 2020 | 141 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3790 | 0.040 |
Why?
|
Endosomes | 1 | 2002 | 519 | 0.040 |
Why?
|
Carbapenems | 1 | 2020 | 123 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 801 | 0.040 |
Why?
|
Granzymes | 1 | 2020 | 276 | 0.040 |
Why?
|
Oligonucleotide Probes | 1 | 2019 | 418 | 0.040 |
Why?
|
Culicidae | 1 | 2019 | 108 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20509 | 0.040 |
Why?
|
Lassa Fever | 1 | 2019 | 97 | 0.040 |
Why?
|
Receptors, KIR2DL1 | 1 | 2017 | 15 | 0.040 |
Why?
|
Receptors, KIR2DL3 | 1 | 2017 | 17 | 0.040 |
Why?
|
Mucus | 1 | 2020 | 342 | 0.040 |
Why?
|
Antigens, Viral | 1 | 2021 | 980 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2021 | 14495 | 0.040 |
Why?
|
Limit of Detection | 1 | 2018 | 280 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 8515 | 0.040 |
Why?
|
Incidence | 1 | 2015 | 21392 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13262 | 0.040 |
Why?
|
Antigens | 1 | 2023 | 1447 | 0.040 |
Why?
|
Inflammasomes | 1 | 2022 | 530 | 0.030 |
Why?
|
HIV Enteropathy | 1 | 2016 | 4 | 0.030 |
Why?
|
Tuberculin | 1 | 2016 | 64 | 0.030 |
Why?
|
Injections, Intradermal | 1 | 2016 | 116 | 0.030 |
Why?
|
Gene Library | 1 | 2019 | 1060 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2017 | 14372 | 0.030 |
Why?
|
Community-Acquired Infections | 1 | 2020 | 461 | 0.030 |
Why?
|
Nigeria | 1 | 2019 | 762 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1832 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 398 | 0.030 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2016 | 123 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2017 | 410 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2019 | 588 | 0.030 |
Why?
|
Boston | 2 | 2020 | 9280 | 0.030 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2000 | 915 | 0.030 |
Why?
|
Cell Separation | 2 | 2011 | 1720 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2020 | 586 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2018 | 554 | 0.030 |
Why?
|
Time Factors | 4 | 2021 | 40165 | 0.030 |
Why?
|
Protein Conformation | 2 | 2010 | 3969 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 4573 | 0.030 |
Why?
|
Spirometry | 1 | 2018 | 924 | 0.030 |
Why?
|
Transfection | 3 | 2016 | 5781 | 0.030 |
Why?
|
Viral Envelope Proteins | 1 | 1998 | 638 | 0.030 |
Why?
|
Trypsin | 1 | 1995 | 496 | 0.030 |
Why?
|
Hydrolysis | 1 | 1995 | 665 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13630 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3804 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2015 | 290 | 0.030 |
Why?
|
Interleukin-10 Receptor alpha Subunit | 1 | 2013 | 28 | 0.030 |
Why?
|
Immunoglobulin Isotypes | 1 | 2014 | 158 | 0.030 |
Why?
|
Quality Control | 1 | 2016 | 828 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2018 | 1683 | 0.030 |
Why?
|
Peer Group | 1 | 2018 | 674 | 0.030 |
Why?
|
Hybridomas | 1 | 2014 | 442 | 0.030 |
Why?
|
Reference Standards | 1 | 2016 | 1004 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2394 | 0.030 |
Why?
|
Virus Diseases | 1 | 2019 | 720 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6068 | 0.030 |
Why?
|
Genetic Variation | 2 | 2019 | 6551 | 0.030 |
Why?
|
Micromanipulation | 1 | 2012 | 52 | 0.030 |
Why?
|
Cricetulus | 1 | 2014 | 815 | 0.020 |
Why?
|
Neutralization Tests | 1 | 2014 | 728 | 0.020 |
Why?
|
Health Education | 1 | 2018 | 1049 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 9585 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2019 | 1535 | 0.020 |
Why?
|
Immunity, Innate | 2 | 2016 | 3047 | 0.020 |
Why?
|
CHO Cells | 1 | 2014 | 1389 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1440 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 1996 | 1526 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 15757 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 1996 | 1456 | 0.020 |
Why?
|
Epitopes | 2 | 2012 | 2503 | 0.020 |
Why?
|
HIV Long-Term Survivors | 1 | 2010 | 121 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2014 | 1351 | 0.020 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2010 | 139 | 0.020 |
Why?
|
Antibodies, Monoclonal | 3 | 2016 | 9185 | 0.020 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2013 | 824 | 0.020 |
Why?
|
HIV Antigens | 1 | 2010 | 325 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1837 | 0.020 |
Why?
|
Receptors, Interleukin-10 | 1 | 2009 | 49 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2013 | 1737 | 0.020 |
Why?
|
Spleen | 1 | 2015 | 2298 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2627 | 0.020 |
Why?
|
Point Mutation | 1 | 2013 | 1594 | 0.020 |
Why?
|
Antibodies | 1 | 2016 | 2421 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18137 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9530 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 24123 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 1998 | 13451 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3528 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2533 | 0.020 |
Why?
|
Cell Line | 2 | 2017 | 15620 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2471 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 1612 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 1998 | 17624 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3736 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4169 | 0.020 |
Why?
|
HLA Antigens | 1 | 2012 | 1368 | 0.020 |
Why?
|
Nanotechnology | 1 | 2012 | 709 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8158 | 0.020 |
Why?
|
Aged | 4 | 2022 | 169152 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 22023 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6131 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3291 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2011 | 1411 | 0.010 |
Why?
|
Amino Acids | 1 | 2010 | 1714 | 0.010 |
Why?
|
Haplotypes | 1 | 2010 | 2764 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7806 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2010 | 1889 | 0.010 |
Why?
|
Disease | 1 | 2009 | 671 | 0.010 |
Why?
|
Neutrophils | 1 | 2016 | 3767 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5794 | 0.010 |
Why?
|
Colon | 1 | 2011 | 1788 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12427 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2009 | 1765 | 0.010 |
Why?
|
DNA | 1 | 1995 | 7233 | 0.010 |
Why?
|
Rats | 1 | 2017 | 23711 | 0.010 |
Why?
|
Models, Molecular | 1 | 2010 | 5434 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58995 | 0.010 |
Why?
|
DNA Methylation | 1 | 2014 | 4373 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6898 | 0.010 |
Why?
|
Genes, env | 1 | 1998 | 95 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15687 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20080 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 1998 | 555 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2000 | 1433 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12960 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11071 | 0.010 |
Why?
|
Chronic Disease | 1 | 2012 | 9287 | 0.010 |
Why?
|
Transcription Factors | 1 | 2016 | 12103 | 0.010 |
Why?
|
Uterus | 1 | 2000 | 651 | 0.010 |
Why?
|
Infant | 2 | 2014 | 36060 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2000 | 1342 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13314 | 0.010 |
Why?
|
Rectum | 1 | 2000 | 895 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 36290 | 0.010 |
Why?
|
Mutagenesis | 1 | 1998 | 1234 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2753 | 0.010 |
Why?
|
Receptors, CXCR4 | 1 | 1998 | 728 | 0.010 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 1998 | 1348 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12626 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 15789 | 0.010 |
Why?
|
Gene Deletion | 1 | 1998 | 2668 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 65017 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1998 | 3735 | 0.010 |
Why?
|
Binding Sites | 1 | 1998 | 6048 | 0.010 |
Why?
|
Cell Movement | 1 | 2000 | 5206 | 0.000 |
Why?
|